Immunolocalization of cyclophilin in normal and cyclosporin A-treated human lymphocytes

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Cyclosporine A (CsA) is an immunosuppressive drug with a complex mechanism of action.
• Cyclophilin (CPH) is a major intracellular target and binding protein for CsA.

Purpose of the Study:

• To characterize a polyclonal antibody against human cyclophilin (CPH).
• To investigate the effect of CsA treatment on CPH cellular distribution in JURKAT T cells and human lymphocytes.

Main Methods:

• Preparation and characterization of a polyclonal rabbit antibody against human CPH.
• Immunoblotting using JURKAT T cell lysate.
• Indirect immunofluorescence microscopy on JURKAT cells and human lymphocytes.
• Complementary staining with rhodamine-phalloidin to assess F-actin distribution.

Main Results:

• The antibody specifically recognized an 18-kDa protein corresponding to CPH.
• Immunofluorescence revealed granular CPH structures in untreated JURKAT cells and lymphocytes.
• CsA treatment significantly altered CPH distribution, showing weaker overall reaction and new 'star-like' or filamentous structures.
• Similar CPH redistribution was observed in lymphocytes from patients undergoing CsA therapy.
• CsA treatment induced changes in F-actin distribution in JURKAT cells.

Conclusions:

• CsA treatment induces significant alterations in the cellular localization of cyclophilin (CPH).
• These observed changes in CPH distribution may play a role in the therapeutic efficacy of CsA.
• The findings provide insights into the molecular mechanisms underlying CsA's action.